Background Hydroxychloroquine has recently received Emergency Use Authorization by the
FDA and is currently prescribed in combination with azithromycin for COVID-19 pneumonia. …

Background Hydroxychloroquine, a drug commonly used in the treatment of rheumatoid
arthritis, has received much negative publicity for adverse events associated with its …

Purpose To compare the incidence of diabetic ketoacidosis (DKA) among patients with type
2 diabetes mellitus (T2DM) who were new users of sodium glucose co‐transporter 2 …

Purpose of Review Risk is an important parameter to describe the occurrence of health
outcomes over time. However, many outcomes of interest in healthcare settings, such as disease …

Light‐chain (AL) amyloidosis is a multisystem disorder with a high early mortality and diagnostic
delays of >1 year from symptom onset. This retrospective observational study sought to …

Objectives Concern has been raised in the rheumatology community regarding recent regulatory
warnings that HCQ used in the coronavirus disease 2019 pandemic could cause acute …

BACKGROUND In 2010, the Louisiana Asthma Management and Prevention Program ( LAMP
) implemented the Asthma‐Friendly Schools Initiative in high‐risk Louisiana populations. …

Background As the US population ages and non‐Hodgkin lymphoma (NHL)–specific
mortality declines, deaths from causes other than NHL will become increasingly important in …

Objectives This study evaluated data from six Swedish national registries to fill current evidence
gaps on the epidemiology, clinical burden, and overall survival (OS) associated with light…

Background: We described the demographics, cancer subtypes, comorbidities, and outcomes
of patients with a history of cancer and coronavirus disease 2019 (COVID-19). Second, we …